Lamivudine
Who holds supplier records for Lamivudine? 15 organisations hold a current record for Lamivudine: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11) and China (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Lamivudine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/lamivudine
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
11 of the 14 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Lamivudine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 24947, 18252, 24609 · latest filing May 2011
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 23601, 18713 · latest filing Feb 2010
- Laurus Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 32633, 31854 · latest filing Mar 2018
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17750, 29613 · latest filing Sept 2015
- Arene Life Sciences LimitedIndiaCEPActive DMF 39124 · latest filing Nov 2023
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 21764, 17535, 21763 · latest filing Sept 2008
- Shanghai Desano Chemical Pharmaceutical Co., LtdChinaCEPActive DMF 21278 · latest filing Jan 2008
- Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.ChinaCEPActive DMF 22982 · latest filing Jul 2009
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 34310 · latest filing Nov 2019
- VIVIN DRUGS AND PHARMACEUTICALS LTDCEPActive DMF 33891 · latest filing Jun 2019
- EMNAR PHARMA PRIVATE LTDIndiaActive DMF 42114 · latest filing Jun 2025
- Lupin LimitedIndia Company GMP cert on recordActive DMF 27007, 21230, 36401 · latest filing Dec 2021
- STYRAX LIFE SCIENCES PRIVATE LIMITEDIndiaActive DMF 35920 · latest filing Jun 2021
- Viyash Scientific LtdIndia Company GMP cert on recordActive DMF 37303 · latest filing Feb 2023
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 26739 · latest filing Jan 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Lamivudine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 18 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2014-034 - Rev 06 Lamivudine, SVL Process | Aug 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2019-082 - Rev 02 Lamivudine, LML Process, form-II | Jun 2026 | — |
| SHIJIAZHUANG LONZEAL PHARMACEUTICALS CO., LTD. Shijiazhuang | CN | CEP 2019-001 - Rev 01 Lamivudine | Apr 2026 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2023-425 - Rev 00 Lamivudine | Mar 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2015-092 - Rev 02 Lamivudine, Form-II, Process-II | Dec 2025 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2007-103 - Rev 04 Lamivudine, Form II | Sept 2025 | — |
| LAURUS LABS LIMITED Hyderabad | IN | CEP 2019-133 - Rev 03 Lamivudine, Process 1 | Feb 2025 | — |
| ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy | IN | CEP 2022-248 - Rev 01 Lamivudine | Sept 2024 | — |
| SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town | CN | CEP 2015-272 - Rev 01 Lamivudine | Jun 2024 | — |
| VIVIN DRUGS & PHARMACEUTICALS PRIVATE LIMITED Hyderabad | IN | R0-CEP 2019-189 - Rev 01 Lamivudine | May 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Lamivudine are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- TIANJIN SEGA PHARMA CO LTDInactive DMF 27247 · filed Jun 2013
- TIANISH LABORATORIES PRIVATE LTDInactive DMF 23431 · filed Jan 2010
- RANBAXY LABORATORIES LTDInactive DMF 20638, 23321 · filed Dec 2009
- SIBRA PHARMACEUTICALS LTD AN ARCH ENTERPRISEInactive DMF 21549 · filed Apr 2008
- India · Inactive DMF 21548 · filed Apr 2008
- ANHUI BIOCHEM PHARM CO LTDInactive DMF 20468 · filed Mar 2007
- India · Inactive DMF 20067 · filed Dec 2006
- India · Inactive DMF 17900 · filed Dec 2004
Overview
Lamivudine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL141).
Chemical identity
- IUPAC name
- 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
- Canonical SMILES
- C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
- InChIKey
- JTEGQNOMFQHVDC-NKWVEPMBSA-N
- Synonyms
- 3TC, BCH 189, (-)-, Epivir, Epivir-hbv, GR 109714X, GR-109714X, GR109714X, Lamivudina, Lamivudine, Lamivudine component of cimduo, Lamivudine component of combivir, Lamivudine component of delstrigo
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Mechanism of action
- Nucleoside Reverse Transcriptase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Lamivudine?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Lamivudine: Hetero Labs Limited (India), APITORIA PHARMA PRIVATE LTD (India), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Arene Life Sciences Limited (India), Cipla Limited (India), Shanghai Desano Chemical Pharmaceutical Co., Ltd (China) and Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. (China), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Lamivudine Drug Master Files are active?
Hetero Labs Limited (DMF 24947, 18252), APITORIA PHARMA PRIVATE LTD (DMF 23601, 18713), Laurus Labs Limited (DMF 32633, 31854), MATRIX PHARMACORP PRIVATE LTD (DMF 17750, 29613), Arene Life Sciences Limited (DMF 39124), Cipla Limited (DMF 21764, 17535), Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 21278) and Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. (DMF 22982) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Lamivudine records mean?
8 organisations have only inactive Type II DMFs for Lamivudine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Lamivudine have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Lamivudine on the EDQM register, including MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), HETERO LABS LIMITED Hyderabad (IN), SHIJIAZHUANG LONZEAL PHARMACEUTICALS CO., LTD. Shijiazhuang (CN), SMS PHARMACEUTICALS LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and CIPLA LIMITED Mumbai (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Lamivudine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Lamivudine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.